Forecast & Rating7 analysts currently cover Accel ENT, with about 71.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $15.57, about 38.2% upside from the current price of $11.27. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Accel ENT closely still see room for the stock to rise. Data as of Sep 15, 2026; for reference only and not investment advice.
Sep 15, 2026Price forecast
$15.5738.17%
Forecast & RatingBuy
7analysts
- Strong buy57.14%
- Buy14.29%
- Hold28.57%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met0.0%
Stock price$11.27
Avg. target$14.8
High target$16
Low target$13
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.